Maternal and fetal distribution of a phosphorothioate oligonucleotide in rats after intravenous infusion-Reference-Cited by-同舟云学术

Maternal and fetal distribution of a phosphorothioate oligonucleotide in rats after intravenous infusion

Published:2006 Issue:1 Volume:77 Page:22-28
ISSN:1542-9733
Container-title:Birth Defects Research Part B: Developmental and Reproductive Toxicology
language:en
Short-container-title:Birth Defect Res B

Author:

Soucy Nicole V.,Riley Jason P.,Templin Michael V.,Geary Richard,de Peyster Ann,Levin Arthur A.

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Developmental Biology,Toxicology,Embryology

Reference22 articles.

1. A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital warts

2. 1995. Oligonucleotide therapeutics. In: editor. Burger's medicinal chemistry and drug discovery. New York: Wiley. p 863–900.

3. 1998a. Basic principles of antisense therapeutics. In: editor. Handbook of experimental pharmacology. Berlin: Springer-Verlag. p 1–50.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic Acid Pharmaceutical Agents;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023

2. Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals;Nucleic Acid Therapeutics;2021-04-01

3. Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction;Nucleic Acids Research;2020-04-06

4. Reproductive and Developmental Toxicity Testing Strategies for Oligonucleotide-Based Therapeutics;Oligonucleotide-Based Drugs and Therapeutics;2018-06-22

5. Oligonucleotide-based pharmaceuticals: Non-clinical and clinical safety signals and non-clinical testing strategies;Regulatory Toxicology and Pharmacology;2017-11